Linde Work in process decreased by 0.5% to $410.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric declined by 5.1%, from $432.00M to $410.00M. Over 4 years (FY 2020 to FY 2024), Work in process shows an upward trend with a 2.4% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $358.00M | $357.00M | $334.00M | $318.00M | $321.00M | $321.00M | $368.00M | $391.00M | $401.00M | $426.00M | $390.00M | $410.00M | $422.00M | $432.00M | $371.00M | $383.00M | $412.00M | $410.00M |
| QoQ Change | — | -0.3% | -6.4% | -4.8% | +0.9% | +0.0% | +14.6% | +6.3% | +2.6% | +6.2% | -8.5% | +5.1% | +2.9% | +2.4% | -14.1% | +3.2% | +7.6% | -0.5% |
| YoY Change | — | — | — | — | -10.3% | -10.1% | +10.2% | +23.0% | +24.9% | +32.7% | +6.0% | +4.9% | +5.2% | +1.4% | -4.9% | -6.6% | -2.4% | -5.1% |
| % of Inventories | 21.2% | 21.1% | 19.3% | 18.0% | 18.0% | 17.3% | 18.6% | 19.0% | 19.3% | 20.5% | 18.4% | 19.5% | 20.2% | 20.7% | 19.1% | 19.3% | 19.4% | 19.3% |
| Share Change | — | -0.1pp | -1.8pp | -1.3pp | -0.0pp | -0.7pp | +1.3pp | +0.4pp | +0.3pp | +1.2pp | -2.1pp | +1.1pp | +0.6pp | +0.5pp | -1.6pp | +0.2pp | +0.1pp | -0.1pp |
We use cookies for analytics. See our Privacy and Cookie Policy.